ContextVision and AMRA Medical Collaborate on AI-Powered Diagnostics for Fatty Liver Disease

ContextVision, a leader in medical image analysis software, is partnering with AMRA Medical to develop new diagnostic solutions for metabolic dysfunction-associated steatotic liver disease (MASLD), a condition affecting up to a quarter of the world’s population.

The collaboration combines ContextVision’s expertise in AI and ultrasound with AMRA’s proficiency in magnetic resonance imaging (MRI)-based body composition analysis. The goal is to create a novel, non-invasive method for early detection and monitoring of the disease’s progression.

AMRA Medical will contribute its MRI-based technology for measuring liver fat (PDFF), abdominal fat volumes, and muscle status. Their data will enrich the multimodal dataset, enabling correlations between MRI and ultrasound-based biomarkers – strengthening ContextVision’s development of solutions for disease staging.

“As we build our Data Quality business, partnerships like this are crucial,” says Gerald Pötzsch, CEO of ContextVision. “AMRA’s highly detailed MR measurements add significant value to our clinical data pipeline. Together, we are approaching a new standard in liver disease diagnostics – non-invasive, accurate, and scalable.”

Olof Dahlqvist Leinhard, CEO of AMRA Medical, adds: “We are excited to be part of ContextVision’s broader initiative to redefine liver diagnostics. Our combined technologies provide a more complete and personalized view of the patient’s health status.”

The initiative strengthens ContextVision’s growing network of research partners, which already includes the University of Washington (USA), the University of Waterloo (Canada), and InPhase Solutions (Norway).

About ContextVision

ContextVision is a software company specializing in image analysis and artificial intelligence. As a global market leader in image enhancement, we are a trusted partner to leading manufacturers of ultrasound, X-ray, and MRI equipment around the world. Our expertise is in developing powerful software products, based on proprietary technology and artificial intelligence for image-based applications. Our pioneering technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnoses and treatment. The company, founded in 1983, is based in Sweden with local representation in the USA, Japan, China and Korea. ContextVision is listed on the Oslo Stock Exchange under the ticker CONTX.

About AMRA Medical

AMRA Medical is a health informatics and precision medicine company pioneering body composition analysis. The company’s groundbreaking technology enables multiple biomarkers for fat and muscle – based on rapid whole-body MRI scans. AMRA supports both research and clinical care through its innovative platform, with the goal of simplifying decision-making and driving the development of future care.

---

Enjoyed this post by Thibault Helle? Subscribe for more insights and updates straight from the source.